SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,007 | -49.1% | 14,561 | -52.1% | 0.03% | -60.3% |
| Q4 2022 | $3,941 | -99.9% | 30,412 | -13.7% | 0.08% | -7.1% |
| Q3 2022 | $3,896,000 | +1039.2% | 35,248 | +704.2% | 0.08% | +950.0% |
| Q1 2022 | $342,000 | +40.7% | 4,383 | +62.3% | 0.01% | +100.0% |
| Q4 2021 | $243,000 | -94.5% | 2,701 | -95.2% | 0.00% | -95.2% |
| Q2 2021 | $4,405,000 | +812.0% | 56,657 | +773.8% | 0.08% | +730.0% |
| Q1 2021 | $483,000 | +0.8% | 6,484 | +130.6% | 0.01% | -28.6% |
| Q4 2020 | $479,000 | -78.7% | 2,812 | -80.0% | 0.01% | -87.5% |
| Q2 2020 | $2,250,000 | -58.2% | 14,034 | -65.6% | 0.11% | -40.4% |
| Q2 2018 | $5,388,000 | +480.6% | 40,761 | +48.1% | 0.19% | +571.4% |
| Q2 2017 | $928,000 | -61.3% | 27,517 | -66.0% | 0.03% | -62.2% |
| Q1 2017 | $2,395,000 | -81.9% | 80,929 | -62.5% | 0.07% | -76.2% |
| Q3 2016 | $13,260,000 | +1617.6% | 215,933 | +798.1% | 0.31% | +1096.2% |
| Q3 2015 | $772,000 | – | 24,042 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |